BridgeMD
Tests treatment safety and results for Metabolic Syndrome (MetS)
Official title Effectiveness and Implementation of a Community-based Health Coach-led Artificial Intelligence (AI)-Powered Digital Self-Regulation Program for Individuals With Metabolic Syndrome (MetS)
ClinicalTrials.gov ID: NCT07410325
What this study is testing
- What it's testing
- This study aims to evaluate the effectiveness of the Lifestyle Intervention for Gentle, Healthy Transformation and Enhanced Weight Reduction-metabolic syndrome (LIGHTER-MetS) program on dietary self-regulation and cardiovascular risk among individuals with metabolic syndrome (MetS). The LIGHTER-MetS program, a community-based, grassroots-led initiative, integrates health coaching with the eTRIP© app to promote sustainable lifestyle changes focusing on diet, exercise, and emotion regulation.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 to 65
You may be able to join if
- are between 21 to 65 years of age;
- have a waist circumference ≥90 cm in men and ≥80 cm in women;
- have 2 or more of the following to be classified as having metabolic syndrome:
- triglyceride level of ≥1.7 mmol/L or on specific treatment for this lipid abnormality;
- high density lipoprotein (HDL) cholesterol \<1.03 mmol/L in men, and \<1.29 mmol/L in women, or on specific treatment for this lipid abnormality;
You likely can't join if
- underwent or are scheduled for metabolic surgery within 1 year;
- are pregnant or planning for pregnancy at the time of recruitment;
- are unable to speak English;
- do not own a smartphone; and
- are unable to provide informed consent.
See the full eligibility criteria
- are between 21 to 65 years of age;
- have a waist circumference ≥90 cm in men and ≥80 cm in women;
- have 2 or more of the following to be classified as having metabolic syndrome:
- triglyceride level of ≥1.7 mmol/L or on specific treatment for this lipid abnormality;
- high density lipoprotein (HDL) cholesterol \<1.03 mmol/L in men, and \<1.29 mmol/L in women, or on specific treatment for this lipid abnormality;
- blood pressure of ≥130/85 mmHg or on treatment of previously diagnosed hypertension;
- fasting blood glucose level of ≥ 5.6 mmol/L or previously diagnosed type 2 diabetes;
- are not receiving other structured lifestyle modification programs;
- consent to audio-recording;
- English speaking and literate.
- underwent or are scheduled for metabolic surgery within 1 year;
- are pregnant or planning for pregnancy at the time of recruitment;
- are unable to speak English;
- do not own a smartphone; and
- are unable to provide informed consent.
The study team makes the final eligibility decision.
Where it's taking place
- Singapore, Singapore
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Singapore, Singapore. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.